The findings highlight the potential benefits of newer biologics targeting IL-12, IL-23, and IL-17 while also raising ...

Biologics targeting interleukin-12, -23, and -17 were associated with a lower rate of serious infections among older adults ...

Learn more about whether Jazz Pharmaceuticals plc or Johnson & Johnson is a better investment based on AAII's A+ Investor ...

Discover predictions for upcoming dividend increases from top companies with long-term growth. Learn which stocks to watch ...

IL-23, or IL-17 reduced serious infections, while tofacitinib increased infection risk, according to one study.

My first experience with the condition was in my third year in high school. It started as subtle red bumps along my hairline, ...

AUSTIN, Texas, March 25, 2025 (GLOBE NEWSWIRE) -- via IBN – Soligenix Inc. (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on ...

It was, says 48-year-old Andrea Dowden, 'one of the worst experiences of my life'. The raised, red scabs, which seemed to ...

Delve into the kinase inhibitors' diverse landscape, from cancer breakthroughs to autoimmune disease innovations.

Eli Lilly and Company, AbbVie, Merck & Co., Inc., Pfizer, D-Wave Quantum, Johnson & Johnson, and Amgen are the seven ...